Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division
Ms. Herman is a life sciences executive with extensive experience developing commercialization strategies and building commercial teamsAUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced the appointment of Rayna Sethi Herman as President of the Company’s hydrocortisone acetate (HCA) commercial division. Ms. Herman will focus on launch execution and strategy for the Company’s
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.